Cannabis Science Highlights Additional Attendees at the Washington DC, African Union, CFA African Healthcare Infrastructure Forum and Brainstorm on February 6, 2015
PR Newswire - Wed Feb 11, 12:20PM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.
Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair of the CFA Africa Healthcare Infrastructure Initiative Committee
PR Newswire - Mon Feb 09, 8:30AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today announced the appointment of Cannabis Science President & CEO, Raymond C. Dabney as Vice Chair of the newly launched Constituency for Africa (CFA) Africa Healthcare Infrastructure Committee. ( www.cfa-network.org ) (https://www.facebook.com/pages/Constituency-for-Africa/347822291974589 )
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Cannabis Science Reports 'CBS This Morning' Interview; US Surgeon General Believes Medical Cannabis 'Can Be Helpful' and Suggests Federal Policy Should Be Driven by Scientific Data
PR Newswire - Thu Feb 05, 6:55AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today applauds US Surgeon General Vivek Murphy who announced yesterday in an interview on 'CBS This Morning' that "we have some preliminary data showing that for certain medical conditions and symptoms that marijuana can be helpful." Surgeon General Vivek also said that scientific data should drive federal medical cannabis policy, and he is "very interested to see where that data takes us."
Cannabis Science (CBIS) Provides Guidance on the Company's New Year and Products, Developments and 'Initiatives in Action' for 2015
PR Newswire - Mon Feb 02, 7:15AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today announced several updates and significant progress on product commercialization and key developments domestically and internationally from the Americas to Africa to Hong Kong, a key door to Asia.
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Cannabis Science (CBIS) Issues Upbeat Report on its Subsidiary, Michigan Green Technologies (MGT), as Historic Michigan Milestone is Reached with New Hemp Legislation
PR Newswire - Thu Jan 29, 10:12AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to issue an update regarding its subsidiary, Michigan Green Technologies LLC (MGT), and the positive evolution of the Michigan legal landscape.
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Cannabis Science, Inc. (CBIS) Gets Set to Release its 8 Initial Cannabis-Based Products Produced and Distributed in California, Spain, and the Netherlands for Self-Medicating Patient Usage for Critical Ailments and Pre-Clinical Studies
PR Newswire Europe - Fri Jan 16, 10:15AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced on January 5th the International release of eight initial products to be produced, distributed and marketed across the Netherlands, Spain and California, where Cannabis Science is active and has cannabis production facilities through ownership and usage agreements.
Pot Stock Millionaires: Hemp Inc. - Part III
Matthew Finston - at Seeking Alpha - Mon Jan 12, 6:14AM CST
Cannabis Industry & Legal Marijuana Opportunities Become Hot Topic for 2015 as Product Commercialization Programs Improve Cultivation Operations
PR Newswire - Tue Jan 06, 7:45AM CST
As more and more medical marijuana dispensaries open in approved states, Cannabis/Marijuana Companies and Providers look for improved technology for innovative methods that address the energy and resources for intensive nature of indoor/outdoor cannabis cultivation. Companies in focus today are: Surna Inc. (OTC: SRNA), Cannabis Science, Inc. (OTC: CBIS), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH) and Easton Pharmaceuticals Inc. (OTC: EAPH) and Terra Tech Corp (OTC: TRTC).
GWPH: 78.09 (+1.70)